CMAJ has been made aware of errors in an article published May 27, 2024.1

The header for point 2 has been revised to “Syphilis POCTs can be administered by trained individuals in a variety of settings.” The header for point 3 has been revised to “The first syphilis POCT licensed in Canada detects treponemal antibodies.” The first sentence of point 4 has been revised to “Treponemal POCTs cannot distinguish active from prior syphilis infections, so are not informative for individuals with previous infections.”

These errors have been corrected at cmaj.ca.